Angle PLC Announces Presentation of Data on Glioblastoma
CLINICAL study SHOWS DETECTION OF CTCs in glioblastoma PatientsGBM CTC isolation only possible with Parsortix label-free methodologyData presented at the...
Brain
Datasea Reports Record Fiscal Year 2025 Revenue of $71.62 Million, Up 199% Year-over-Year
DTSS Achieves Fourth Quarter Net Income Breakeven Driven byCutting-Edge Acoustics and AI Multimodal Digitalization; Ongoing Commercialization Updates in the Coming Weeks BEIJING,...
“Mr. Fix-It,” Lou Manfredini, Spotlights Genesis+HOCl as a Breakthrough Against Airborne Mold on HouseSmarts Radio
FREDERICK, Md., Sept. 26, 2025 /PRNewswire/ -- For more than 30 years, Lou Manfredini—better known as Mr. Fix-It—has been America's trusted...
Shape Therapeutics Announces Multiple Oral and Poster Presentations at the European Society of Gene & Cell Therapy 32nd Annual Congress
Talks will cover the use of a novel BBB-penetrant, AAV5-derived CNS capsid and development of an RNA-targeting disease-modifying gene therapy,...
MMJ’s FDA Cannabis Softgel Capsule Could Be the Real Game Changer for Huntington’s – Gene Therapy Sparks Hope
MMJ BioPharma Cultivation is completing its Cannabis DEA bulk manufacturing license process, a seven-year DEA battle that has delayed the...
Brain Balance Onboards with ProsperityEHR to Strengthen Care for ADHD, Autism, and Learning Challenges
Partnership equips Brain Balance to scale its national network with a unified EHR that integrates clinical, financial, and operational workflows,...
MDisrupt Welcomes American Heart Association Professional Members to Its Platform, Unlocking Faster Innovation in Heart and Brain Health
The addition of cardiology and neurology experts helps health companies scale evidence-based health products with confidence AUSTIN, Texas, Sept. 25,...
Sensi.AI Hosts “Sensi by the Shore” Retreat for Leaders in Senior Care
Immersive AI Education & Experience for Home Care and Senior Living Leaders Not Yet Using Sensi PALO ALTO, Calif., Sept....
National Ataxia Foundation Partners with Biogen to Bring Bill Nye “the Science Guy” Back To the Lab With New Series About Friedreich Ataxia
MINNEAPOLIS, Sept. 25, 2025 /PRNewswire/ -- The National Ataxia Foundation (NAF) today announced the launch of The Science Guy: Back in...
Jaguar Health Receives Notice of $250,000 FDA Grant to Fund Confirmatory Trial to Support FDA Approval of Canalevia for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs
Company strategy: In discussions with multiple potential animal health company partners to expand the indication and commercialize Canalevia for treatment...
Moleculin Announces Notice of Allowance for Canadian Patent Covering Annamycin
HOUSTON, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company...
Nexalin Technology Announces Issuance of U.S. Patent Covering HALO™ Clarity Device Featuring DIFS™ Technology
HOUSTON, TX, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”), the leader...
Clene Presents New Clinical Data at ECTRIMS 2025 Meeting Demonstrating CNM-Au8® Improves Brain Energy Metabolism in Multiple Sclerosis Patients
Late-breaking clinical data presented at the 41st Congress of the European Committee for Treatment and Research in Multiple Sclerosis Across non-active...
Helius Announces FDA 510(k) Submission for PoNS® Device Label Expansion in Stroke
Seeking an indication for gait and balance deficit in patients with chronic symptoms of stroke under its Breakthrough Device DesignationNEWTOWN,...
Algernon Announces CAD $4 Million Non-Dilutive Financing to Open Four Brain-Specific PET Scan Clinics in the U.S. for Early Stage Alzheimer’s Detection
VANCOUVER, British Columbia, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB:...
Peer-reviewed results from Phase 1b/2a Trial of Anti-pTau Active Immunotherapy from AC Immune Published in eBioMedicine
Peer-reviewed results from Phase 1b/2a Trial of Anti-pTau Active Immunotherapy from AC Immune Published in eBioMedicine Detailed results from completed...
Breakthrough San Diego Clinic Uses Cutting-Edge NUCCA Technique to Reverse Chronic Pain and Restore Quality of Life – Without Drugs or Surgery
San Diego-based Origin Modern Health & Wellness uses powerful, gentle root cause care, reconnecting individuals to their body's potential. SAN...
15th Annual Nikon Small World in Motion Competition Winner Magnifies Self-Pollination Process in a Common Wildflower
Time-lapse video of a thymeleaf speedwell reveals the reproductive strategy select plants may adopt when pollinators are scarce MELVILLE, N.Y., Sept....
FYR Closes $8 Million Financing to Advance Blood-Based Biomarkers Across Oncology and Neuroscience
The Sontag Innovation Fund and the Yuvaan Tiwari Foundation join Two Bear Capital to support FYR's growing oncology portfolio and...
NUCALM IGNITES THE POWER OF VOICE WITH CELEBRATED COACH ROGER LOVE
Harnessing Neuroscience and Voice Mastery to Transform How Humans Communicate and Connect LOS ANGELES, Sept. 24, 2025 /PRNewswire/ -- NuCalm®,...